Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus
- 1 March 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 284 (3) , L508-L517
Abstract
Although vascular endothelial growth factor (VEGF) plays a vital role in lung vascular growth in the embryo, its role in maintaining endothelial function and modulating vascular structure during late fetal life has not been studied. We hypothesized that impaired lung VEGF signaling causes pulmonary hypertension, endothelial dysfunction, and structural remodeling before birth. To determine whether lung VEGF expression is decreased in an experimental model of persistent pulmonary hypertension of the newborn (PPHN), we measured lung VEGF and VEGF receptor protein content from fetal lambs 7–10 days after ductus arteriosus ligation (132–140 days gestation; term = 147 days). In contrast with the surge in lung VEGF expression during late gestation in controls, chronic intrauterine pulmonary hypertension reduced lung VEGF expression by 78%. To determine whether VEGF inhibition during late gestation causes pulmonary hypertension, we treated fetal lambs with EYE001, an aptamer that specifically inhibits VEGF165. Compared with vehicle controls, EYE001 treatment elevated pulmonary artery pressure and pulmonary vascular resistance by 22 and 50%, respectively, caused right ventricular hypertrophy, and increased wall thickness of small pulmonary arteries. EYE001 treatment reduced lung endothelial nitric oxide synthase protein content by 50% and preferentially impaired the pulmonary vasodilator response to ACh, an endothelium-dependent agent. We conclude that chronic intrauterine pulmonary hypertension markedly decreases lung VEGF expression and that selective inhibition of VEGF165 mimics the structural and physiological changes of experimental PPHN. We speculate that hypertension downregulates VEGF expression in the developing lung and that impaired VEGF signaling may contribute to the pathogenesis of PPHN.Keywords
This publication has 45 references indexed in Scilit:
- Expression of Vascular Endothelial Growth Factor and Flk-1 in Developing and Glucocorticoid-Treated Mouse LungPediatric Research, 2000
- Vascular Endothelial Growth Factor Gene Expression in Human Fetal Lung In VitroAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Increased Vascular Endothelial Growth Factor Production in the Lungs of Rats with Hypoxia-induced Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Early Fetal Development of Lung VasculatureAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Recovery of Disturbed Endothelium-Dependent Flow in the Collateral-Perfused Rabbit Ischemic Hindlimb After Administration of Vascular Endothelial Growth FactorCirculation, 1995
- Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birthAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990
- Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs.Journal of Clinical Investigation, 1989
- The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth.Thorax, 1982
- The Number of Alveoli in the Terminal Respiratory Unit of Man During Late Intrauterine Life and ChildhoodArchives of Disease in Childhood, 1960